Maladaptive Daydreaming Test
How the Scales are Structured
Who Usually Takes This Test?
See How You Compare
Below is a preview of how scores are typically distributed across each scale.
Once you complete the test, your result will appear on the scale so you can see how you compare.
Example Questions From the Test
- Never
- 10%
- 20%
- 30%
- 40%
- 50%
- 60%
- 70%
- 80%
- 90%
- 100% Very often
- No urge at all
- 10%
- 20%
- 30%
- 40%
- 50%
- 60%
- 70%
- 80%
- 90%
- 100% The urge is extremely strong
- Never
- 10%
- 20%
- 30%
- 40%
- 50%
- 60%
- 70%
- 80%
- 90%
- 100% Almost always
This self-report measure is designed to screen for maladaptive daydreaming and associated functional interference. Developed by Eli Somer, the Maladaptive Daydreaming Test uses the Maladaptive Daydreaming Scale (MDS-16) to rate the frequency, intensity, and perceived impact of immersive fantasy activity on daily functioning. It includes 16 items and typically takes about 3 minutes to complete.
Why Take a Maladaptive Daydreaming Test
Daydreaming is a normal, common experience — but for some people, it becomes something categorically different: hours-long, vivid, absorbing fantasy episodes that are difficult to control and actively interfere with work, relationships, and daily responsibilities. Because maladaptive daydreaming disorder is not yet formally recognized in the DSM, many people who experience it spend years without a name for what's happening, often assuming they simply have poor willpower or an unusually active imagination.
A structured test for maladaptive daydreaming provides language and validation where none previously existed. Rather than describing the experience in vague terms, the MDS-16 asks about specific, observable patterns — how strongly music or real-life triggers pull someone into fantasy, how distressing it feels to be interrupted, and how much it interferes with important goals. This specificity matters because maladaptive daydreaming frequently co-occurs with ADHD, anxiety, depression, and OCD-related conditions, making a validated screening tool valuable for clarifying what's actually happening before pursuing broader evaluation.
This maladaptive daydreaming disorder test is especially useful for people who suspect their daydreaming has crossed from an enjoyable escape into something that consumes disproportionate time and interferes with functioning — and who want a research-based starting point for understanding the pattern.
What the Assessment Measures
The MDS-16 covers 16 items assessing core features of maladaptive daydreaming:
- Trigger sensitivity — how strongly external cues such as music or real-life events pull a person into immersive daydreaming
- Urge and control difficulty — the strength of the urge to return to daydreaming after interruption, and difficulty staying focused on tasks instead
- Distress and interference — how much daydreaming disrupts performance at school or work, and how distressing the amount of time spent is
- Preference over other activities — the extent to which daydreaming is preferred over socializing, hobbies, or other engagement with the real world
- Physical and emotional features — accompanying physical movements during daydreaming episodes, and the enjoyment or calming quality of the fantasy itself
Higher scores indicate more pronounced maladaptive daydreaming features and greater functional interference. Results are for screening and severity estimation only.
Who This Assessment Is For
This Maladaptive Daydreaming Test is appropriate for anyone who notices that immersive fantasy or daydreaming episodes are consuming significant time, interfering with responsibilities, or difficult to control despite wanting to stop. It is also relevant for people already diagnosed with ADHD, anxiety, depression, or OCD-related conditions, given the documented overlap between these conditions and maladaptive daydreaming, and for clinicians seeking a brief, validated screening tool.
Clinical Validity and Use in Practice
The MDS-16 was developed and validated by Eli Somer and colleagues and is widely used in maladaptive daydreaming research internationally. It is intended for use as a brief screening instrument and should be interpreted in the context of clinical interview and other assessment data — results do not provide a diagnosis on their own, as maladaptive daydreaming disorder is not yet a formally recognized clinical diagnosis. Where scores indicate significant severity, consultation with a mental health professional familiar with maladaptive daydreaming is recommended, particularly to evaluate overlapping conditions such as ADHD, anxiety, or dissociative symptoms.